JOTEC


Artivion is dedicated to advancing aortic technologies with purpose, developing simple, elegant solutions for cardiac and vascular surgeons to treat diseases of the aorta. They focus on innovative, life-changing aortic-centric technologies to improve surgical outcomes and patient lives.

Industries

health-care
medical-device

Nr. of Employees

large (251-1000)

JOTEC

Hechingen, Baden-Wurttemberg, Germany, Europe


Patents

Expandable vascular implant

US-11844680-B2

View Details

Intraluminal vascular prosthesis

US-11826271-B2

View Details

Intraluminal vessel prosthesis system

US-11684497-B2

View Details

Stent graft with pockets

US-11484399-B2

View Details

Vascular prosthesis with side branches

US-10952840-B2

View Details

Balloon catheter

US-10898359-B2

View Details
View All Patents

Products

On-X® Aortic Heart Valve

A mechanical heart valve designed for aortic valve replacement.

On-X® Ascending Aortic Prosthesis

Prosthesis for ascending aorta replacement.

On-X® Mitral Heart Valve

A mechanical mitral valve for mitral valve replacement.

Chord-X® Mitral Chordal Replacement Products

Chordal replacement system for mitral valve repair.

CryoValve® SG Pulmonary Human Heart Valve

Pulmonary valve allograft.

CryoValve® Aortic Allograft

Aortic valve allograft.

View All Products

Services

Aortic Valve Solutions

Providing a range of aortic heart valves and related products.

Allografts

Offering cardiac and vascular allograft tissues such as cryovalves, cryopatches, cryografts, and cryoarteries.

Aortic Arch Solutions

Developing hybrid prostheses and stent graft systems for aortic arch treatment.

Thoracoabdominal Solutions

Providing thoracic and abdominal stent graft systems.

Abdominal Aorta Stent Grafts

Offering E-TEGRA and E-LIAC stent graft systems.

Peripheral Aorta Stent Grafts

Providing E-LIAC stent graft systems and Tuva BX.

View All Services

News & Updates

Presentation of real-world data from post-market study of On-X® Aortic Heart Valve patients treated with low dose warfarin.

Study to evaluate the safety and efficacy of the AMDS Hybrid Prosthesis for acute DeBakey Type I aortic dissections.

Prospective, single-arm, multi-center clinical investigation to evaluate the safety and effectiveness of AMDSTM in the treatment of acute DeBakey Type I dissection.

Sale of PerClot to Baxter International, Inc.

Analysis of clinical outcomes across the full 93 study participant IDE cohort at one year following AMDS implantation.

FDA approval for use of the AMDS Hybrid Prosthesis in acute DeBakey Type I dissections with malperfusion.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.